{"pmid":32292696,"pmcid":"PMC7138191","title":"COVID-19 Infection Unmasking Brugada Syndrome.","text":["COVID-19 Infection Unmasking Brugada Syndrome.","HeartRhythm Case Rep","Chang, David","Saleh, Moussa","Garcia-Bengo, Youssef","Choi, Evan","Epstein, Laurence","Willner, Jonathan","32292696"],"journal":"HeartRhythm Case Rep","authors":["Chang, David","Saleh, Moussa","Garcia-Bengo, Youssef","Choi, Evan","Epstein, Laurence","Willner, Jonathan"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292696","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.hrcr.2020.03.012","keywords":["Brugada syndrome","COVID-19","Coronavirus","Electrocardiogram","Syncope"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664266295796826113,"score":8.233237,"similar":[{"pmid":32244059,"title":"SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.","text":["SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.","Ever since the first case was reported at the end of 2019, the SARS-COV-2 virus and associated lung disease COVID-19 has spread throughout the world and has become a pandemic. In particular, the high transmission rate of the virus has made it a threat to public health globally. Currently, there is no proven effective therapy against the virus, and the impact on other diseases is also uncertain, especially inherited arrhythmia syndrome. Arrhythmogenic effect of COVID-19 can be expected, potentially contributing to disease outcome. This may be of importance for patients with an increased risk for cardiac arrhythmias, either secondary to acquired conditions or co-morbidities or consequent to inherited syndromes. Management of patients with inherited arrhythmia syndromes such as Long QT syndrome, Brugada syndrome, Short QT syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia in the setting of the COVID-19 pandemic may prove particularly challenging. Depending on the inherited defect involved, these patients may be susceptible to pro-arrhythmic effects of COVID-19-related issues such as fever, stress, electrolyte disturbances and use of antiviral drugs. We here describe the potential COVID-19 associated risks and therapeutic considerations for patients with distinct inherited arrhythmia syndromes and provide recommendations, pending local possibilities, for their monitoring and management during this pandemic.","Heart Rhythm","Wu, Cheng-I","Postema, Pieter G","Arbelo, Elena","Behr, Elijah R","Bezzina, Connie R","Napolitano, Carlo","Robyns, Tomas","Probst, Vincent","Schulze-Bahr, Eric","Remme, Carol Ann","Wilde, Arthur A M","32244059"],"abstract":["Ever since the first case was reported at the end of 2019, the SARS-COV-2 virus and associated lung disease COVID-19 has spread throughout the world and has become a pandemic. In particular, the high transmission rate of the virus has made it a threat to public health globally. Currently, there is no proven effective therapy against the virus, and the impact on other diseases is also uncertain, especially inherited arrhythmia syndrome. Arrhythmogenic effect of COVID-19 can be expected, potentially contributing to disease outcome. This may be of importance for patients with an increased risk for cardiac arrhythmias, either secondary to acquired conditions or co-morbidities or consequent to inherited syndromes. Management of patients with inherited arrhythmia syndromes such as Long QT syndrome, Brugada syndrome, Short QT syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia in the setting of the COVID-19 pandemic may prove particularly challenging. Depending on the inherited defect involved, these patients may be susceptible to pro-arrhythmic effects of COVID-19-related issues such as fever, stress, electrolyte disturbances and use of antiviral drugs. We here describe the potential COVID-19 associated risks and therapeutic considerations for patients with distinct inherited arrhythmia syndromes and provide recommendations, pending local possibilities, for their monitoring and management during this pandemic."],"journal":"Heart Rhythm","authors":["Wu, Cheng-I","Postema, Pieter G","Arbelo, Elena","Behr, Elijah R","Bezzina, Connie R","Napolitano, Carlo","Robyns, Tomas","Probst, Vincent","Schulze-Bahr, Eric","Remme, Carol Ann","Wilde, Arthur A M"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32244059","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.hrthm.2020.03.024","keywords":["Brugada syndrome","COVID-19","Catecholaminergic Polymorphic ventricular tachycardia","Long QT syndrome","SARS-CoV-2","Short QT syndrome"],"source":"PubMed","locations":["Brugada"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663352135748681728,"score":82.43993},{"pmid":32285915,"title":"Typical takotsubo syndrome triggered by SARS-CoV-2 infection.","text":["Typical takotsubo syndrome triggered by SARS-CoV-2 infection.","Eur Heart J","Meyer, Philippe","Degrauwe, Sophie","Delden, Christian Van","Ghadri, Jelena-Rima","Templin, Christian","32285915"],"journal":"Eur Heart J","authors":["Meyer, Philippe","Degrauwe, Sophie","Delden, Christian Van","Ghadri, Jelena-Rima","Templin, Christian"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32285915","week":"202016|Apr 13 - Apr 19","doi":"10.1093/eurheartj/ehaa306","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664071627181129729,"score":51.547417},{"pmid":32240279,"title":"Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?","text":["Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?","BACKGROUND: The amelioration of the current COVID pandemic relies on swift and efficient case finding as well as stringent social distancing measures. Current advice suggests that fever or new onset dry cough are the commonest presenting complaints. METHODOLOGY: We present a case report and case series as well as other evidence that there is an important fourth presenting syndrome, namely isolated sudden onset anosmia (ISOA), which should be considered highly suspicious for SARS-CoV-2. RESULTS: A patient presenting with ISOA who went on to test positive for infection with COVID-19 and did not develop any further symptoms as well as a case series of similar patients although limited by the lack of reliable testing at the moment. CONCLUSIONS: We posit the existence of a fourth common syndrome of COVID-19 infection: isolated sudden onset anosmia (ISOA) and urge the international community to consider this presentation in current management advice.","Rhinology","Gane, S B","Kelly, C","Hopkins, C","32240279"],"abstract":["BACKGROUND: The amelioration of the current COVID pandemic relies on swift and efficient case finding as well as stringent social distancing measures. Current advice suggests that fever or new onset dry cough are the commonest presenting complaints. METHODOLOGY: We present a case report and case series as well as other evidence that there is an important fourth presenting syndrome, namely isolated sudden onset anosmia (ISOA), which should be considered highly suspicious for SARS-CoV-2. RESULTS: A patient presenting with ISOA who went on to test positive for infection with COVID-19 and did not develop any further symptoms as well as a case series of similar patients although limited by the lack of reliable testing at the moment. CONCLUSIONS: We posit the existence of a fourth common syndrome of COVID-19 infection: isolated sudden onset anosmia (ISOA) and urge the international community to consider this presentation in current management advice."],"journal":"Rhinology","authors":["Gane, S B","Kelly, C","Hopkins, C"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240279","week":"202014|Mar 30 - Apr 05","doi":"10.4193/Rhin20.114","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663352135607123970,"score":50.89539},{"pmid":32270413,"title":"A family cluster of severe acute respiratory syndrome coronavirus 2 infections.","text":["A family cluster of severe acute respiratory syndrome coronavirus 2 infections.","Clinical and epidemiological knowledge of 2019 novel coronavirus disease (COVID-19) is limited. We reported a family cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases in Beijing, China. This family comprised three laboratory confirmed cases with clinical symptoms. All three patients had close contact with a relative from Wuhan, Hubei Province. Throat swab samples were all positive for SARS-CoV-2 using real-time reverse transcriptase-polymerase chain reaction assays. Chest computerized tomography revealed ground-glass opacities and consolidation. SARS-CoV-2 infections tend to clusters. Physicians should be aware of contact history so that infected patients can be identified promptly and further spreading prevented.","Eur J Clin Microbiol Infect Dis","Gao, Xuesong","Yuan, Zheng","Yang, Di","Li, Hongjie","Zhang, Yijin","Gao, Ping","Liu, Xiaomin","Zhao, Wenshan","Xiao, Te","Duan, Xuefei","32270413"],"abstract":["Clinical and epidemiological knowledge of 2019 novel coronavirus disease (COVID-19) is limited. We reported a family cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases in Beijing, China. This family comprised three laboratory confirmed cases with clinical symptoms. All three patients had close contact with a relative from Wuhan, Hubei Province. Throat swab samples were all positive for SARS-CoV-2 using real-time reverse transcriptase-polymerase chain reaction assays. Chest computerized tomography revealed ground-glass opacities and consolidation. SARS-CoV-2 infections tend to clusters. Physicians should be aware of contact history so that infected patients can be identified promptly and further spreading prevented."],"journal":"Eur J Clin Microbiol Infect Dis","authors":["Gao, Xuesong","Yuan, Zheng","Yang, Di","Li, Hongjie","Zhang, Yijin","Gao, Ping","Liu, Xiaomin","Zhao, Wenshan","Xiao, Te","Duan, Xuefei"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270413","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s10096-020-03880-1","source":"PubMed","locations":["Beijing","Wuhan","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1663620082990841856,"score":50.53737},{"pmid":32289085,"pmcid":"PMC7143583","title":"A novel presentation of COVID-19 via community acquired infection.","text":["A novel presentation of COVID-19 via community acquired infection.","Vis J Emerg Med","Jansen, Jaclyn H","Day, Rachel L","32289085"],"journal":"Vis J Emerg Med","authors":["Jansen, Jaclyn H","Day, Rachel L"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289085","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.visj.2020.100760","keywords":["COVID-19","Coronavirus","Lung disease","SARS-CoV-2","Viral"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664071627196858368,"score":50.38141}]}